A Mason teenager is facing serious charges after investigators allegedly found AI-generated sexual images of underage classmates in his possession. Mason City Schools officials said there are multiple ...

Abstract: Permutation entropy (PE) is a widely used metric for quantifying the complexity of time series data. Recent efforts have extended PE to graph signals, resulting in the graph permutation ...

Generate Biomedicines shares dropped nearly 21% Friday after the company’s $400 million initial public offering, continuing an uneven recovery for biotech stock-market debuts. After a biotech IPO ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate Biomedicines Inc. raised $400 million in an initial public offering, pricing its shares at the midpoint of the marketed range. At the IPO price, Generate would have a market value of about $2 ...

Boolean options: -n, --dry-run Don't actually minify the file(s), just show if they will be processed. -d, --include-dotfolders Include dotfolders in file search. -D, --include-dotfiles Include ...

I recently saw a tweet showing how Google has acquired companies over the years and built products around them. Here is the link to the tweet if you want. Now, Google made another announcement: Google ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 million in an initial public offering, as listing activity in ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Somerville company aims to ...

The Columbia Generating Station, the Tri-Cities’ only nuclear power plant, is offline after crews identified an issue with water pumps in the reactors. In response, the Bonneville Power Administration ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...